Cas:7790-81-0 cadmium(2+),diiodate manufacturer & supplier

We serve Chemical Name:cadmium(2+),diiodate CAS:7790-81-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

cadmium(2+),diiodate

Chemical Name:cadmium(2+),diiodate
CAS.NO:7790-81-0
Synonyms:Cadmium iodate;cadmium(2+) diiodate;Iodic acid,cadmium salt (8CI);Bisiodic acid cadmium salt;EINECS 232-224-1;CTK2H9457
Molecular Formula:CdI2O6
Molecular Weight:462.21600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:114.40000
Exact Mass:463.68200
LogP:1.05610

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2570 6.1/PG 3
Packing Group:II


Contact us for information like Cadmium iodate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,CTK2H9457 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cadmium iodate Use and application,Iodic acid,cadmium salt (8CI) technical grade,usp/ep/jp grade.


Related News: For example, there are concerns that PFAS’ effect on the thyroid could lead to thyroid cancer, van Gerwen said. cadmium(2+),diiodate manufacturer Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated. cadmium(2+),diiodate supplier The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route. cadmium(2+),diiodate vendor In order to find answers to these questions, our staff in the development department set about conducting a series of experiments. cadmium(2+),diiodate factory The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful.